Nanjing Xinbell Pharmaceutical Technology Co., Ltd. was established in October 2014. It is located in Nanjing, Jiangsu Province, in the Yangtze River Delta Region. Xinbell is a professional company specializing in developing, producing and marketing of pharmaceutical intermediates.
The company’s products are mainly involved in the field of anti-tumor, epilepsy, rheumatism, cardiovascular and cerebrovascular and have been sold to more than ten countries, such as Europe, India, Japan, South Korea and Southeast Asia. At the present, the company cooperates with three GMP complied factories and two domestic university and R & D center.